F-star Therapeutics, Inc.
FSTX · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $112 | $135 | $75 | $104 |
| - Cash | $36 | $53 | $69 | $79 |
| + Debt | $13 | $13 | $13 | $13 |
| Enterprise Value | $89 | $95 | $19 | $38 |
| Revenue | $1 | $0 | $3 | $17 |
| % Growth | – | -100% | -85.4% | – |
| Gross Profit | $1 | $0 | $3 | $17 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$18 | -$18 | -$12 | $4 |
| % Margin | -1,580.4% | – | -452.1% | 20.4% |
| Net Income | -$18 | -$19 | -$12 | $5 |
| % Margin | -1,641.5% | – | -476.1% | 27.1% |
| EPS Diluted | -0.84 | -0.89 | -0.58 | 0.23 |
| % Growth | 5.6% | -53.4% | -352.2% | – |
| Operating Cash Flow | -$17 | -$17 | -$12 | $7 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$17 | -$17 | -$12 | $7 |